A Performance Comparison of Commonly Used Assays to Detect RET Fusions

PURPOSE: Selpercatinib and pralsetinib induce deep and durable responses in advanced RET fusion-positive lung and thyroid cancer patients. RET fusion testing strategies with rapid and reliable results are critical given recent FDA approval. Here, we assess various clinical assays in a large pan-canc...

Full description

Saved in:
Bibliographic Details
Published in:Clin Cancer Res
Main Authors: Yang, Soo-Ryum, Aypar, Umut, Rosen, Ezra Y., Mata, Douglas A., Benayed, Ryma, Mullaney, Kerry, Jayakumaran, Gowtham, Zhang, Yanming, Frosina, Denise, Drilon, Alexander, Ladanyi, Marc, Jungbluth, Achim, Rekhtman, Natasha, Hechtman, Jaclyn F.
Format: Artigo
Language:Inglês
Published: 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285056/
https://ncbi.nlm.nih.gov/pubmed/33272981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-3208
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items